Real-time enrollment status for this pdac - pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:30 PM UTC
| NCT Number | NCT07047807 |
| Recruiting Status | Recruiting |
| Condition | PDAC - Pancreatic Ductal Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | April 20, 2026 (Apr 20, 2026) |
As of July 13, 2026: Clinical trial NCT07047807 is currently recruiting participants. This clinical trial study for pdac - pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07047807 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07047807 was last updated Apr 20, 2026 (April 20, 2026). HelloStudys verifies this status automatically.